Navigation Links
Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements
Date:5/24/2013

he close of business on 22 May 2013, being the last practicable date prior to this announcement, BofA Merrill Lynch and persons controlling, controlled by or under the same control as BofA Merrill Lynch (except in any such case, in the capacity of an exempt market marker, and excluding any exempt fund manager) were interested in 439,332 Elan ADSs and 749,900 derivatives referenced to Elan ADSs.

As at the close of business on 22 May 2013, being the last practicable date prior to this announcement, BofA Merrill Lynch and persons controlling, controlled by or under the same control as BofA Merrill Lynch (except in any such case, in the capacity of an exempt market marker, and excluding any exempt fund manager) held short positions in 759,312 Elan ADSs.

As at the close of business on 22 May 2013, being the last practicable date prior to this announcement, Locus Global I, LP, an entity controlled by Rory Riggs , a director of RP Management (Ireland) Limited was interested in 772 Elan ADSs.

Save as disclosed above, as at the close of business on 22 May 2013, being the last practicable date prior to this announcement, none of Royalty Pharma, RP Management or any person acting in concert with Royalty Pharma or RP Management had any interest, or held any short position, in any relevant securities of Elan.

About Royalty Pharma

RP Management is the investment manager to entities investing in royalty interests in marketed and late stage biopharmaceutical products, with a portfolio of royalty interests in 38 approved and marketed products (including Abbott's Humira®, Johnson and Johnson's Remicade®, Merck's Januvia®, Gilead's Atripla®, Truvada®, and Emtriva®, Pfizer's Lyrica®, Amgen's Neupogen® and Neulasta®, and Genentech's Rituxan®) and two products pending approval. Such product portfolio is well-diversified across biopharmaceutical prod
'/>"/>

SOURCE Royalty Pharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Royalty Pharma Reduces Acceptance Condition to 50% Plus One Share
2. Royalty Pharma Increases Offer for Elan to $12.50 Per Share in All Cash
3. Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
4. PDL BioPharma Completes Structured Financing and Royalty Transaction with Avinger
5. Royalty Rates for Pharmaceuticals & Biotechnology: Real-Deal Information for Hundreds of Transactions
6. PDL BioPharma Provides First Quarter 2013 Royalty Revenue Guidance of $92 Million
7. Royalty Pharma Announces Proposal To Acquire Elan
8. Royalty Rates Take Center Stage in Biopharma Dealmaking
9. Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland
10. Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients
11. Intercept Pharmaceuticals to Present at Deutsche Bank Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 2015  Elusys Therapeutics, Inc. (Elusys) today announced ... accepted for filing and review its Biologics License ... and prevention of inhalational anthrax, a top bioterror ... Anthim is a candidate for future acquisition into ... of critical medical supplies for biowarfare preparedness. Anthim ...
(Date:6/1/2015)... VEGAS , June 1, 2015 A ... make a landmark decision, with billion dollar implications, in ... Attorneys representing patients who suffered severe effects of bladder ... in a Las Vegas courtroom ... a jury decides, not the question of responsibility, but ...
(Date:6/1/2015)... 2015  MicroVention, Inc., a wholly owned subsidiary of ... that it will build its new 205,000 square-foot worldwide ... Aliso Viejo, CA , the city where the ... ceremony to commemorate the start of construction will be ... the site where the new headquarters building will be ...
Breaking Medicine Technology:U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 2U.S. Food And Drug Administration Accepts Biologics License Application For Anthim (Obiltoxaximab) 3Landmark Decision Expected In Actos Trial 2MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo 2MicroVention to Locate Its New 205,000 Square-Foot Worldwide Headquarters At Summit Office Campus in Aliso Viejo 3
... 2012  Delcath Systems, Inc. (NASDAQ: DCTH ) ... initial launch and training agreement for the Delcath Hepatic ... Roussy ("IGR"), a leading European cancer center located in ... Company will provide the IGR with logistics and clinical ...
... March 15, 2012 LifeSecure Insurance Company ... shop where caregivers can access quality home care products ... loved ones. LifeSecure,s Caregiver,s Marketplace offers ... aids and home modification tools to medical supplies. It ...
Cached Medicine Technology:Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 2Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 3Delcath Announces Agreement With Institut Gustave Roussy for Launch of Hepatic CHEMOSAT Delivery System in France 4LifeSecure Opens Online Caregiver's Marketplace 2
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Miriam Wirski as a 2015-2016 inductee into its ... with this prestigious distinction for leadership in business. NAPW ... women, boasting more than 700,000 members and over 200 ... with this prestigious honor,” said NAPW President Star Jones. ...
(Date:6/1/2015)... June 02, 2015 The National ... Cade as a 2015-2016 inductee into its VIP ... this prestigious distinction for leadership in business. NAPW is ... boasting more than 700,000 members and over 200 operating ... this important honor,” said NAPW President Star Jones. “Her ...
(Date:6/1/2015)... 2015 Carson Energy also announced they ... IRA transactions. AdvantaIRA Trust, LLC is the country’s largest ... to fund positions using IRA’s does 2 things:, 1. ... project, even if there current cash position will not ... source for Carson and their investors to be able ...
(Date:6/1/2015)... The Delta Dental Foundation is currently seeking applications ... Ohio and Indiana for its Brighter Futures Community Grants ... been set. , Across the tri-state area, the program ... focus on children’s oral health and $100,000 in grants ... Each grant request will be considered and carefully reviewed ...
(Date:6/1/2015)... June 01, 2015 EBSCO Health ... today introduced DynaMed Plus™ , a cross-platform evidence-based ... professionals. It provides clinicians with the ideal blend of ... care paths. , DynaMed Plus is a significant ... includes the most frequently updated evidence-based content. DynaMed Plus ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Linda Cade, Senior Product Manager at Sage, Into its VIP Professional Woman of the Year Circle 2Health News:Carson Energy Brings Oil Wells To IRAs 2Health News:Brighter Futures Community Grants Program Seeks to Help Fund Local Oral Health Programs 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
... Stereotaxis, Inc. (Nasdaq: STXS ) today reported strong revenue ... expenses and a significant reduction in the net loss for ... 30, 2009. Revenue for the recent third quarter totaled ... the 2008 third quarter. During the quarter, the Company ...
... LLC a wholly owned subsidiary of Superior Global Solutions, Inc. ... announced that it has completed its acquisition of the assets ... of medical documentation and workflow management software based in Marietta, ... top healthcare clients across the US. Under the terms of ...
... ... Texas, is launching a powerful new website complete with the latest tools of the internet. Author ... using his website as an educational resource for visitors seeking treatment for an array of skin ... (Vocus) November 5, 2009 -- ...
... ... developer of intellectual property rights management systems. , ... London, UK (PRWEB) November 5, 2009 -- Rights management ... investor YFM Group., , , , ,Also following their existing investment was the Creative Capital ...
... The ... a reality as Thailand continues to see an increase in medical tourism. With an annual ... of Thailand (TAT) and the Department of Export Promotion (DEP) expects to see two million ... ...
... ... Global Solutions, Inc. a leader in healthcare outsourcing, today announced that it has completed ... provider of medical documentation and workflow management software based in Marietta, Georgia. , ... Plano, TX (PRWEB) November ...
Cached Medicine News:Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 2Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 3Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 4Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 5Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 6Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 7Health News:Stereotaxis Reports 26% Third Quarter 2009 Revenue Growth 8Health News:Superior Global Solutions, Inc. Acquires HTI Technologies, Inc. 2Health News:Houston and New York Cosmetic Dermatologist Paul M. Friedman, MD Launches Expansive New Website 2Health News:Houston and New York Cosmetic Dermatologist Paul M. Friedman, MD Launches Expansive New Website 3Health News:Rights Tracker Completes Fundraising 2Health News:Thailand's Medical Tourism is Booming - Thailand on its Way to Become Asia's Medical Hub 2Health News:Thailand's Medical Tourism is Booming - Thailand on its Way to Become Asia's Medical Hub 3Health News:Superior Global Solutions, Inc. Acquires HTI Technologies, Inc. 2Health News:Superior Global Solutions, Inc. Acquires HTI Technologies, Inc. 3
... (T4) is the primary active hormone synthesized ... gland [1]. T4 is synthesized via a ... by the follicular cells, (ii) iodination of ... to formation of 3-monoiodotyrosine and 3,5-diiodotyrosine (MIT ...
... Triiodothyronine (T3) is produced primarily by 5-monodeioination ... the thyroid gland, T3 production occurs at ... that for T4. Release of T3 from ... ~5-8 micrograms/day as compared to 80-100 micrograms/day ...
... a monomeric protein produced and stored in ... is released from the pituitary into the ... regulatory control of hypothalamic somatostatin (SS) and ... frequency of GH release appears to be ...
... monomeric protein produced and stored in somatotrophs ... released from the pituitary into the bloodstream ... control of hypothalamic somatostatin (SS) and GH-releasing ... of GH release appears to be regulated ...
Medicine Products: